JP2023518777A5 - - Google Patents
Info
- Publication number
- JP2023518777A5 JP2023518777A5 JP2022556478A JP2022556478A JP2023518777A5 JP 2023518777 A5 JP2023518777 A5 JP 2023518777A5 JP 2022556478 A JP2022556478 A JP 2022556478A JP 2022556478 A JP2022556478 A JP 2022556478A JP 2023518777 A5 JP2023518777 A5 JP 2023518777A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- formula
- compound according
- compound
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2020/081295 | 2020-03-26 | ||
| CN2020081295 | 2020-03-26 | ||
| CN2021078391 | 2021-03-01 | ||
| CNPCT/CN2021/078391 | 2021-03-01 | ||
| PCT/CN2021/083013 WO2021190601A1 (en) | 2020-03-26 | 2021-03-25 | Cyclophilin inhibitors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023518777A JP2023518777A (ja) | 2023-05-08 |
| JP2023518777A5 true JP2023518777A5 (cg-RX-API-DMAC7.html) | 2024-04-05 |
| JP7776435B2 JP7776435B2 (ja) | 2025-11-26 |
Family
ID=77891510
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556477A Active JP7761578B2 (ja) | 2020-03-26 | 2021-03-25 | シクロスポリン誘導体の調製 |
| JP2022556478A Active JP7776435B2 (ja) | 2020-03-26 | 2021-03-25 | シクロフィリン阻害剤およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556477A Active JP7761578B2 (ja) | 2020-03-26 | 2021-03-25 | シクロスポリン誘導体の調製 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US12673976B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4126905B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7761578B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20220158760A (cg-RX-API-DMAC7.html) |
| CN (2) | CN115335389A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021240762A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022018929A2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3172535A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3074820T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL296586B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022011697A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI917366B (cg-RX-API-DMAC7.html) |
| WO (2) | WO2021190601A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111449050A (zh) * | 2019-01-20 | 2020-07-28 | 睿诺医疗科技(上海)有限公司 | 环孢菌素类似物及其用途 |
| CN116870135A (zh) | 2019-10-12 | 2023-10-13 | 睿诺医疗科技(上海)有限公司 | 肾毒素诱发的肾损伤的治疗和预防 |
| CA3172535A1 (en) | 2020-03-26 | 2021-09-30 | Ching-Pong Mak | Cyclophilin inhibitors and uses thereof |
| AU2021256222A1 (en) | 2020-04-15 | 2022-10-06 | Farsight Medical Technology (Shanghai) Co., Ltd. | Prevention and treatment of organ injuries |
| GB202207348D0 (en) * | 2022-05-19 | 2022-07-06 | Cypralis Ltd | Macrocyclic compounds and uses thereof |
| TW202438040A (zh) * | 2023-03-03 | 2024-10-01 | 大陸商睿諾醫療科技(上海)有限公司 | 劑誘導的肝臟病症或疾病的治療和預防 |
| WO2024245384A1 (en) * | 2023-06-02 | 2024-12-05 | Farsight Medical Technology (Shanghai) Co., Ltd. | Cyclophilin inhibitors and uses thereof |
| WO2026119135A1 (en) * | 2024-12-03 | 2026-06-11 | Farsight Medical Technology (Shanghai) Co., Ltd. | Cyclophilin inhibitors and uses thereof |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0194972B1 (en) | 1985-03-11 | 1992-07-29 | Sandoz Ag | Novel cyclosporins |
| FI111730B (fi) | 1990-11-02 | 2003-09-15 | Novartis Ag | Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi |
| DE69832984T2 (de) * | 1997-10-08 | 2006-09-21 | Isotechnika, Inc., Edmonton | DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN |
| ATE254630T1 (de) | 1998-06-12 | 2003-12-15 | Chem Ag C | Cyclosporine |
| US6809077B2 (en) | 2001-10-12 | 2004-10-26 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogs for the treatment of autoimmune diseases |
| DK1436322T3 (da) | 2001-10-19 | 2008-11-03 | Isotechnika Inc | Blandinger af cyclosporinanaloger og deres anvendelse som immunmodulerende midler |
| CA2518265A1 (en) | 2003-03-17 | 2004-09-30 | Albany Molecular Research, Inc. | Novel cyclosporins |
| JP2007532507A (ja) * | 2004-04-08 | 2007-11-15 | ノバルティス アクチエンゲゼルシャフト | 脳虚血ならびに脳および脊髄傷害の処置のためのサイクロスポリンの使用 |
| PT1802650E (pt) * | 2004-10-01 | 2011-12-30 | Scynexis Inc | Derivados da ciclosporina 3-éter e 3-tioéter substituída para o tratamento e prevenção da infecção de hepatite c |
| CN101068829B (zh) * | 2004-10-01 | 2012-05-30 | 西尼克斯公司 | 用于治疗和预防丙型肝炎病毒感染的3-醚和3-硫醚取代的环孢菌素衍生物 |
| CA2652662C (en) * | 2006-05-19 | 2015-11-03 | Scynexis, Inc. | Methods for the treatment and prevention of ocular disorders |
| WO2008143996A1 (en) * | 2007-05-18 | 2008-11-27 | Scynexis, Inc. | New chemical processes |
| MX2011001152A (es) | 2008-07-30 | 2011-06-09 | Isotechnika Pharma Inc | Moleculas de analogo de ciclosporina no-inmunesupresoras. |
| RU2492181C2 (ru) | 2009-01-30 | 2013-09-10 | Энанта Фармасьютикалс, Инк. | Аналоги циклоспорина для предупреждения или лечения инфекции гепатита с |
| US8481483B2 (en) | 2009-02-19 | 2013-07-09 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| CA2785978A1 (en) * | 2009-12-30 | 2011-07-07 | Scynexis, Inc. | Cyclosporine analogues |
| US9217015B2 (en) | 2010-07-16 | 2015-12-22 | S&T Global Inc. | Cyclosporin derivatives for the treatment and prevention of a viral infection |
| US9890198B2 (en) | 2010-12-03 | 2018-02-13 | S&T Global Inc. | Cyclosporin derivatives and uses thereof |
| AU2011342284C1 (en) | 2010-12-15 | 2017-07-13 | Contravir Pharmaceuticals, Inc. | Cyclosporine analogue molecules modified at amino acid 1 and 3 |
| DE102011111991A1 (de) | 2011-08-30 | 2013-02-28 | Lead Discovery Center Gmbh | Neue Cyclosporin-Derivate |
| GB201217560D0 (en) | 2012-10-02 | 2012-11-14 | Mitopharm Ltd | Novel cyclic depsipeptide compounds and their uses |
| US20140213508A1 (en) | 2012-10-19 | 2014-07-31 | Scynexis, Inc. | Antiviral macrocycles |
| GB201222455D0 (en) | 2012-12-13 | 2013-01-30 | Perioc Ltd | Novel pharmaceutical formulations and their use in the treatment of periodontaldisease |
| GB201414806D0 (en) | 2014-08-20 | 2014-10-01 | Ucl Business Plc | Cyclosporin conjugates |
| CN108025039B (zh) | 2015-06-30 | 2022-07-29 | 西普拉里斯有限公司 | 新颖的大环化合物 |
| CN106902347A (zh) * | 2015-12-23 | 2017-06-30 | 中美华世通生物医药科技(武汉)有限公司 | 亲环孢素抑制剂的用途 |
| CN106902346A (zh) | 2015-12-23 | 2017-06-30 | 中美华世通生物医药科技(武汉)有限公司 | 药物组合物及其制药用途 |
| AU2017267560B2 (en) * | 2016-05-17 | 2022-03-24 | S&T Global Inc. | Novel cyclosporin derivatives and uses thereof |
| GB201711749D0 (en) * | 2017-07-21 | 2017-09-06 | Cypralis Ltd | Cyclosporin analogues and uses thereof |
| WO2020037530A1 (en) | 2018-08-22 | 2020-02-27 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Crystalline form of compound and uses thereof in medicine |
| CN111449050A (zh) | 2019-01-20 | 2020-07-28 | 睿诺医疗科技(上海)有限公司 | 环孢菌素类似物及其用途 |
| CN116870135A (zh) | 2019-10-12 | 2023-10-13 | 睿诺医疗科技(上海)有限公司 | 肾毒素诱发的肾损伤的治疗和预防 |
| CA3172535A1 (en) | 2020-03-26 | 2021-09-30 | Ching-Pong Mak | Cyclophilin inhibitors and uses thereof |
| AU2021256222A1 (en) | 2020-04-15 | 2022-10-06 | Farsight Medical Technology (Shanghai) Co., Ltd. | Prevention and treatment of organ injuries |
-
2021
- 2021-03-25 CA CA3172535A patent/CA3172535A1/en active Pending
- 2021-03-25 CN CN202180023394.0A patent/CN115335389A/zh active Pending
- 2021-03-25 CA CA3172601A patent/CA3172601A1/en active Pending
- 2021-03-25 JP JP2022556477A patent/JP7761578B2/ja active Active
- 2021-03-25 WO PCT/CN2021/083013 patent/WO2021190601A1/en not_active Ceased
- 2021-03-25 KR KR1020227036439A patent/KR20220158760A/ko active Pending
- 2021-03-25 BR BR112022018929A patent/BR112022018929A2/pt unknown
- 2021-03-25 CN CN202180023172.9A patent/CN115298199A/zh active Pending
- 2021-03-25 EP EP21776894.4A patent/EP4126905B1/en active Active
- 2021-03-25 US US17/906,348 patent/US12673976B2/en active Active
- 2021-03-25 JP JP2022556478A patent/JP7776435B2/ja active Active
- 2021-03-25 MX MX2022011697A patent/MX2022011697A/es unknown
- 2021-03-25 KR KR1020227036440A patent/KR20220158761A/ko active Pending
- 2021-03-25 TW TW110110800A patent/TWI917366B/zh active
- 2021-03-25 AU AU2021240762A patent/AU2021240762A1/en active Pending
- 2021-03-25 WO PCT/CN2021/083016 patent/WO2021190604A1/en not_active Ceased
- 2021-03-25 ES ES21776894T patent/ES3074820T3/es active Active
- 2021-03-25 EP EP21776582.5A patent/EP4126904A4/en active Pending
-
2022
- 2022-09-16 US US17/946,071 patent/US12060440B2/en active Active
- 2022-09-18 IL IL296586A patent/IL296586B2/en unknown
-
2024
- 2024-06-26 US US18/754,189 patent/US12522634B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7067792B2 (ja) | 新たなピラジン誘導体及びその調製方法並びに医薬応用 | |
| CA2691446A1 (en) | Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses | |
| JPS62249923A (ja) | パ−キンソン病、うつ病、ナルコレプシ−および脳器官精神症候群の抑制用薬剤およびその製造方法 | |
| JP6628252B2 (ja) | 虚血性眼疾患の処置用の医薬組成物 | |
| JP2023518775A5 (cg-RX-API-DMAC7.html) | ||
| CN104083385B (zh) | 闭花木酮Cleistanone的O-(哌啶基)乙基衍生物在制备升高白细胞的药物中的应用 | |
| CN108239095A (zh) | 一类吡喃并咔唑生物碱及其制备方法和其药物组合物与用途 | |
| FR3107897A1 (fr) | Dérivés de nicotinamide mononucléotides | |
| CN110372614A (zh) | 一种四氢喹喔啉类化合物及制备方法与应用 | |
| HU202106B (en) | Process for producing pharmaceutical compositions containing pyrazolin derivatives | |
| RU2258700C1 (ru) | Четвертичное аммониевое производное лидокаина, обладающее противоаритмической активностью и способ его получения | |
| RU2770033C2 (ru) | Композиции и способы лечения инфекционных заболеваний ротовой полости | |
| JP2012518671A5 (cg-RX-API-DMAC7.html) | ||
| CN103396368B (zh) | 氮氧自由基在治疗缺血再灌注损伤中的应用 | |
| JPS60158149A (ja) | 炎症抑制作用を有する1,4‐ナフトキノン誘導体 | |
| RU2002102495A (ru) | Новые производные ксантона, их получение и применение в качестве лекарственного средства | |
| CN102718653A (zh) | 一类防治心、脑血管疾病的前体药物 | |
| CN109180712B (zh) | 一类2-茨醇的芳基硼酸酯衍生物及其应用 | |
| WO2016184122A1 (zh) | 一种吡唑类化合物 | |
| CN117327028B (zh) | 吩噻嗪类衍生物、药物组合物及其在治疗棘球蚴病中的用途 | |
| CN115504902A (zh) | 5-氯水杨酰胺类衍生物、其制备方法及其作为药物的用途 | |
| JP2021024835A (ja) | 小腸潰瘍改善剤 | |
| JP2007516980A (ja) | 2つの金(i)原子が該2つの金(i)原子を接続している共有リンクにおいてそれぞれ炭素原子に共有結合された化合物の、癌の治療のための使用 | |
| CN114409610B (zh) | 噁二唑衍生物及其制备方法和用途 | |
| JP7426756B2 (ja) | チオベンゾピラン系化合物及び関節リウマチの治療薬の調製におけるその使用 |